GW Link

Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Tribal Opioid Response (TOR) Grants

Grants to USA Tribes and Tribal Organizations to
Increase Access to Treatment for Opioid Use Disorder

Agency Type:

Federal

Funding Source:

Add to My Calendar 

U.S. Department of Health and Human Services (DHHS) - Substance Abuse and Mental Health Services Administration (SAMHSA)

Conf. Date:

07/11/19

Deadline Date:

08/06/19 11:59 PM ET

Description:

Request a Grant Writer

Grants starting at $50,000 to USA tribes and tribal organizations to address the opioid epidemic impacting tribal communities. Applicants are advised to verify or create the required registrations well in advance of the deadline. Funding is intended to increase access to culturally-appropriate and evidence-based treatment including medication-assisted treatment (MAT) using one of the three FDA-approved medications for the treatment of opioid use disorder (OUD). The intent is to reduce unmet treatment need and opioid overdose-related deaths through the provision of prevention, treatment and/or recovery activities for OUD.

Grantees will develop and provide opioid misuse prevention, treatment, and recovery support services for the purposes of addressing the opioid abuse and overdose crisis within the tribes. This service array should be based on needs identified in the Tribe’s strategic plan. Grantees will be required to report expenditures for all activities and ensure available resources within the tribe are leveraged for substance use prevention, treatment, and recovery support services to avoid duplication of efforts.

Additionally, the use of these funds requires that evidence-based treatments, practices and interventions for OUD be used by grantees and subgrantees. SAMHSA requires that Food Drug Administration-approved medication-assisted treatment (MAT) be provided to those diagnosed with OUD. FDA-approved MAT for OUD includes methadone, buprenorphine products, including single-entity buprenorphine products, buprenorphine/naloxone tablets, films, buccal preparations, injectable buprenorphine products, buprenorphine implants, and injectable extended-release naltrexone.

In addition to these treatment services, grantees will be required to employ effective prevention and recovery support services to ensure that individuals are receiving a comprehensive array of services across the spectrum of prevention, treatment, and recovery.

For information on required activities, allowable activities, and other expectations, see pages 7-12 of the FOA: https://www.samhsa.gov/sites/default/files/grants/pdf/tor_2019_final.pdf#page=7

GrantWatch ID#:

GrantWatch ID#: 183970

Estimated Total Program Funding:

$35,985,372

Number of Grants:

Estimated Number of Awards: 163

Estimated Size of Grant:

Funds will be distributed noncompetitively based on the distribution in Appendix K of the FOA (pages 77-81).

If you did not receive a TOR grant in 2018 and your tribe in not listed in Appendix K, you may apply for $50,000.

Term of Contract:

Anticipated Project Start Date: September 30, 2019
Length of Project Period: Up to 2 years

SAMHSA intends that its services programs result in the delivery of services as soon as possible after award. At the latest, award recipients are expected to provide services to the population(s) of focus by the fourth month after the grant has been awarded.

Additional Eligibility Criteria:

The applicant must be a federally recognized American Indian or Alaska Native tribe or tribal organization. Tribes and tribal organizations may apply individually, as a consortia, or in partnership with an urban Indian organization. These entities are defined as follows:

- Indian Tribe, as defined at 25 U.S.C. § 1603(14) is any Indian tribe, band, nation, or other organized group or community, including any Alaska Native village or group or regional or village corporation as defined in or established pursuant to the Alaska Native Claims Settlement Act (85 Stat. 688) [43 U.S.C.A. § 1601 et seq.], which is recognized as eligible for the special programs and services provided by the United States to Indians because of their status as Indians.

- Tribal Organization, as defined at 25 U.S.C. § 1603(26) is the recognized governing body of any Indian tribe; any legally established organization of Indians which is controlled, sanctioned, or chartered by such governing body or which is democratically elected by the adult members of the Indian community to be served by such organization and which includes the maximum participation of Indians in all phases of its activities. Provided that in any case where a contract is let or grant made to an organization to perform services benefiting more than one Indian tribe, the approval of each such Indian tribe shall be a prerequisite to the letting or making of such contract or grant.

- Urban Indian Organization, as defined at 25 U.S.C. § 1603(29), operating pursuant to a contract or grant with the Indian Health Service is a nonprofit corporate body situated in an urban center, governed by an urban Indian controlled board of directors, and providing for the maximum participation of all interested Indian groups and individuals, which body is capable of legally cooperating with other public and private entities for the purpose of performing the activities described in [25 U.S.C § 1653(a)].

A consortia of tribes or tribal organizations are eligible to apply, but each participating entity must indicate its approval. A single tribe in the consortium must be the legal applicant, the recipient of the award, and the entity legally responsible for satisfying the grant requirements.

Funding restrictions: https://www.samhsa.gov/sites/default/files/grants/pdf/tor_2019_final.pdf#page=50

Pre-proposal Conference:

SAMHSA will be hosting four webinars for prospective TOR applicants on how to register for the eRA System, how to use the eRA System to initiate and fill out applications, and how to submit completed applications.
- Thursday, June 20: 11:00-Noon ET
- Tuesday, June 25: 2:00-3:00 PM ET
- Tuesday, July 2: 2:00-3:00 PM ET
- Thursday, July 11: 3:00-4:00 PM ET

To call into the webinar:
Call-In Number: 800-857-6720
Participant passcode: 7458400

Pre-Application Information:

Applications are due by 11:59 PM (Eastern Time) on August 6, 2019.

All applicants must register with NIH’s eRA Commons in order to submit an application. You can find additional information about the eRA Commons registration process at
https://era.nih.gov/reg_accounts/register_commons.cfm.

Applicants must also register with the System for Award Management (SAM) and Grants.gov (see PART II: Section I-1 and Section II-1 in the specific SAMHSA Funding Opportunity Announcement (FOA) for all registration requirements).

It is strongly recommended that applicants start the registration process six (6) weeks in advance of the application due date.

Applying for a New SAMHSA grant: https://www.samhsa.gov/grants/applying

Application forms and resources: https://www.samhsa.gov/grants/applying/forms-resources

View this opportunity on Grants.gov: https://www.grants.gov/web/grants/view-opportunity.html?oppId=316792

For a list of application documents, see the Package tab (press Preview) on the grants.gov link above.

Contact Information:

Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.

Contact Information:

Program Issues
OPIOIDTOR@samhsa.hhs.gov

Grants Management and Budget Issues
Eileen Bermudez
Office of Financial Resources, Division of Grants Management
Substance Abuse and Mental Health Services Administration
(240) 276-1412
FOACSAT@samhsa.hhs.gov

CFDA Number:

93.788

Funding or Pin Number:

TI-19-012

URL for Full Text (RFP):

Geographic Focus:

USA: Alabama;   Alaska;   Arizona;   Arkansas;   California;   Colorado;   Connecticut;   Delaware;   Florida;   Georgia;   Hawaii;   Idaho;   Illinois;   Indiana;   Iowa;   Kansas;   Kentucky;   Louisiana;   Maine;   Maryland;   Massachusetts;   Michigan;   Minnesota;   Mississippi;   Missouri;   Montana;   Nebraska;   Nevada;   New Hampshire;   New Jersey;   New Mexico;   New York City;   New York;   North Carolina;   North Dakota;   Ohio;   Oklahoma;   Oregon;   Pennsylvania;   Rhode Island;   South Carolina;   South Dakota;   Tennessee;   Texas;   Utah;   Vermont;   Virginia;   Washington, DC;   Washington;   West Virginia;   Wisconsin;   Wyoming